换一批Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.
第一作者：
Daniel Y C,Heng
第一单位：
FRCPC, Department of Medical Oncology, Tom Baker Cancer Center, University of Calgary, Calgary, Alberta, Canada. daniel.heng@cancerboard.ab.ca
作者：
医学主题词
老年人(Aged);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤药(Antineoplastic Agents);苯磺酸盐类(Benzenesulfonates);癌, 肾细胞(Carcinoma, Renal Cell);女(雌)性(Female);人类(Humans);吲哚类(Indoles);肾肿瘤(Kidney Neoplasms);男(雄)性(Male);中年人(Middle Aged);烟酰胺(Niacinamide);苯脲化合物(Phenylurea Compounds);预后(Prognosis);吡啶类(Pyridines);吡咯类(Pyrroles);存活率(Survival Rate);血管内皮生长因子A(Vascular Endothelial Growth Factor A)
DOI
10.1200/JCO.2008.21.4809
PMID
19826129
发布时间
2022-04-09
- 浏览53
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
